EPO and anemia: Erythropoiesis-stimulating agents can be used to treat anemia; however, it is unknown whether these agents improve prognosis, and experimental studies indicate that erythropoietin may induce the expression of the vascular endothelial growth factor and stimulate tumor recurrence in mice.